These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 21822173
1. Sensitized recipients exhibit accelerated but not hyperacute rejection of vascularized composite tissue allografts. Wu S, Xu H, Chen B, Wen Y, Ikusika OM, Ocker A, Zhao H, Ildstad ST. Transplantation; 2011 Sep 27; 92(6):627-33. PubMed ID: 21822173 [Abstract] [Full Text] [Related]
2. Humoral immunity in allograft rejection. The role of cytotoxic alloantibody in hyperacute rejection and enhancement of rat cardiac allografts. Oluwole SF, Tezuka K, Wasfie T, Stegall MD, Reemtsma K, Hardy MA. Transplantation; 1989 Nov 27; 48(5):751-5. PubMed ID: 2815247 [Abstract] [Full Text] [Related]
4. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade. Foster RD, Pham S, Li S, Aitouche A. Transplantation; 2003 Sep 27; 76(6):988-94. PubMed ID: 14508367 [Abstract] [Full Text] [Related]
5. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide. Chowdhury NC, Saborio DV, Garrovillo M, Chandraker A, Magee CC, Waaga AM, Sayegh MH, Jin MX, Oluwole SF. Transplantation; 1998 Oct 27; 66(8):1059-66. PubMed ID: 9808492 [Abstract] [Full Text] [Related]
6. Intrathymic immunomodulation in sensitized rat recipients of cardiac allografts: requirements for allorecognition pathways. Stadlbauer TH, Schaub M, Magee CC, Kupiec-Weglinski JW, Sayegh MH. J Heart Lung Transplant; 2000 Jun 27; 19(6):566-75. PubMed ID: 10867337 [Abstract] [Full Text] [Related]
9. The prevention of accelerated cardiac allograft rejection in sensitized recipients after treatment with brequinar sodium. Yasunaga C, Cramer DV, Chapman FA, Wang HK, Barnett M, Wu GD, Makowka L. Transplantation; 1993 Oct 27; 56(4):898-904. PubMed ID: 8212214 [Abstract] [Full Text] [Related]
10. CTLA4-Ig-based conditioning regimen to induce tolerance to cardiac allografts. Li S, Salgar SK, Thanikachalam M, Murdock AD, Gammie JS, Demetris AJ, Zeevi A, Pham SM. J Surg Res; 2006 Dec 27; 136(2):238-46. PubMed ID: 17046021 [Abstract] [Full Text] [Related]
15. Induction of tolerance toward rat cardiac allografts by treatment with allochimeric class I MHC antigen and FTY720. Chueh SC, Tian L, Wang M, Wang ME, Stepkowski SM, Kahan BD. Transplantation; 1997 Nov 27; 64(10):1407-14. PubMed ID: 9392303 [Abstract] [Full Text] [Related]
16. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides. Saborio DV, Chowdhury NC, Jin MX, Chandraker A, Sayegh MH, Oluwole SF. Cell Transplant; 1999 Nov 27; 8(4):375-81. PubMed ID: 10478717 [Abstract] [Full Text] [Related]
19. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts. Colson YL, Zadach K, Nalesnik M, Ildstad ST. Transplantation; 1995 Nov 15; 60(9):971-80. PubMed ID: 7491703 [Abstract] [Full Text] [Related]